Skip to main content

Table 3 Association between ProADM blood levels at baseline and day 7 and 10-year outcomes

From: Pro-Adrenomedullin predicts 10-year all-cause mortality in community-dwelling patients: a prospective cohort study

baseline

New-onset DM

MACCE

Unadjusted HR

0.9 (0.3 to 2.5), p = 0.773

0.8 (0.2 to 2.4), p = 0.634

age-adjusted HR

0.8 (0.3 to 2.3), p = 0.641

0.7 (0.2 to 2.2), p = 0.54

AUC

0.50 (0.12 to 0.87)

0.42 (0.11 to 0.73)

day 7

  

 Unadjusted HR

1.2 (0.4 to 4.1), p = 0.717

1.1 (0.3 to 3.6), p = 0.873

 age-adjusted HR

1.1 (0.3 to 3.7), p = 0.884

0.9 (0.3 to 2.8), p = 0.808

 AUC

0.56 (0.16 to 0.97)

0.53 (0.15 to 0.91)

  1. Data for univariable and bivariable analyses are given as HR (95% CI) and p value. Data regarding prognostic analysis are given as AUC (95%CI). A higher AUC reflects greater accuracy: 0.5, the null value, indicates coin-tossaccuracy, while 1.0, the maximum value, indicates 100% accuracy. P values in bold type are statistically significant at p < 0.05
  2. Univariable model includes: natural logarithmic value of ProADM blood concentrations
  3. Bivariable model includes: natural logarithmic value of ProADM blood concentrations and patient age
  4. MACCE Major cardiovascular and cerebrovascular events, New-onset DM, New- onset diabetes mellitus
Back to article page

BMC Cardiovascular Disorders

ISSN: 1471-2261

Contact us